Health and Healthcare

Merck : MRK

All Merck Articles

1079 Articles

Chris Lange | Aug 27, 2018 at 7:25 AM EDT

Short Sellers Can’t Make Up Their Minds on Major Pharma Stocks

The August 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Paul Ausick | Aug 25, 2018 at 8:40 AM EDT

Nike Back on Top as Dow’s Best-Performing Stock

Nike stock added more than 3% to its share price last week, leading the company to wrestle away from Apple…

Jon C. Ogg | Aug 23, 2018 at 8:45 AM EDT

Top Analyst Upgrades and Downgrades: Aetna, Analog Devices, Lowe’s, Merck, Pfizer, Plug Power, Qualcomm, Target and More

The top analyst upgrades, downgrades and initiations seen on Thursday include Aetna, Analog Devices, Lowe's, Merck, Pfizer, Plug Power, Qualcomm…

Jon C. Ogg | Aug 22, 2018 at 11:10 AM EDT

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

Big Pharma is looking good for investors in the second half of 2018. That's the message from the research team…

Paul Ausick | Aug 20, 2018 at 4:01 PM EDT

Nike, Johnson & Johnson Lift the Dow Monday

Nike, Johnson & Johnson, Merck, and Home Depot were Monday's leading gainers.

Paul Ausick | Aug 18, 2018 at 8:50 AM EDT

Apple Returns to Perch as Dow Top-Performing Stock

After an absence of more than a year, Apple is once more the top-performing Dow stock for the year to…

Jon C. Ogg | Aug 15, 2018 at 11:50 AM EDT

Why Merrill Lynch Sees Health Care Sector Offering Solid Growth, and as Value and Defensive

The latest monthly Merrill Lynch RIC Report is quite favorable on the health care sector as an opportunity for investors.…

Chris Lange | Aug 10, 2018 at 9:50 AM EDT

Short Sellers Hike Bets in Major Pharma Stocks

The July 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jul 27, 2018 at 10:40 AM EDT

Merck Underwhelms Despite Beating Earnings

Merck reported better-than-expected second-quarter results before the markets opened on Friday, but shares retreated afterward.

Chris Lange | Jul 25, 2018 at 7:35 AM EDT

Major Pharma Stocks Scare Off Short Sellers

The July 13 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jul 22, 2018 at 10:40 AM EDT

Boeing, McDonald’s, Intel and More Dow Stocks Reporting This Week

24/7 Wall St. has put together a preview of Boeing, Exxon, Verizon and other Dow industrials scheduled to report their…

Lee Jackson | Jul 20, 2018 at 8:00 AM EDT

Top Analyst Bullish on Big Pharmaceutical Stocks Before Q2 Earnings

Four pharmaceutical industry leaders are poised to report second-quarter results next week, and one key analyst sees the relatively good…

Chris Lange | Jul 12, 2018 at 8:50 AM EDT

Where Did Major Pharma Short Sellers Go?

The June 29 short interest data have been compared with the previous figures, and short interest in most of these…

Paul Ausick | Jul 5, 2018 at 4:01 PM EDT

Intel, Walgreens Pace the Dow Thursday

Intel, Walgreens, Johnson & Johnson, and Merck led the Dow higher Thursday.

Chris Lange | Jul 2, 2018 at 11:10 AM EDT

FDA Accepts Merck’s Keytruda for Review, Sets PDUFA Date

Merck shares retreated to start off the week despite the announcement of good news from the FDA.

1 … 20 21 22 23 24 … 72

Merck : MRK

All Merck Articles

Short Sellers Can’t Make Up Their Minds on Major Pharma Stocks

Nike Back on Top as Dow’s Best-Performing Stock

Top Analyst Upgrades and Downgrades: Aetna, Analog Devices, Lowe’s, Merck, Pfizer, Plug Power, Qualcomm, Target and More

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

Nike, Johnson & Johnson Lift the Dow Monday

Apple Returns to Perch as Dow Top-Performing Stock

Why Merrill Lynch Sees Health Care Sector Offering Solid Growth, and as Value and Defensive

Short Sellers Hike Bets in Major Pharma Stocks

Merck Underwhelms Despite Beating Earnings

Major Pharma Stocks Scare Off Short Sellers

Boeing, McDonald’s, Intel and More Dow Stocks Reporting This Week

Top Analyst Bullish on Big Pharmaceutical Stocks Before Q2 Earnings

Where Did Major Pharma Short Sellers Go?

Intel, Walgreens Pace the Dow Thursday

FDA Accepts Merck’s Keytruda for Review, Sets PDUFA Date

A $620,000 Portfolio That Pays More Than the Average Social Worker’s Salary

Prediction: Pfizer Stock Will Double on This Date

SMH ETF Investors: Watch Hyperscaler Capex Guidance at July Earnings Calls

A $620,000 Portfolio That Pays More Than the Average Social Worker's Salary

The Average American Has Worked for 6 Employers and 23% Still Have Multiple Old Retirement Accounts, Fidelity's 2026 Study Finds

A $620,000 Portfolio That Pays More Than the Average Social Worker’s Salary

Prediction: Pfizer Stock Will Double on This Date

Merck : MRK

All Merck Articles

Short Sellers Can’t Make Up Their Minds on Major Pharma Stocks

Nike Back on Top as Dow’s Best-Performing Stock

Top Analyst Upgrades and Downgrades: Aetna, Analog Devices, Lowe’s, Merck, Pfizer, Plug Power, Qualcomm, Target and More

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

Nike, Johnson & Johnson Lift the Dow Monday

Apple Returns to Perch as Dow Top-Performing Stock

Why Merrill Lynch Sees Health Care Sector Offering Solid Growth, and as Value and Defensive

Short Sellers Hike Bets in Major Pharma Stocks

Merck Underwhelms Despite Beating Earnings

Major Pharma Stocks Scare Off Short Sellers

Boeing, McDonald’s, Intel and More Dow Stocks Reporting This Week

Top Analyst Bullish on Big Pharmaceutical Stocks Before Q2 Earnings

Where Did Major Pharma Short Sellers Go?

Intel, Walgreens Pace the Dow Thursday

FDA Accepts Merck’s Keytruda for Review, Sets PDUFA Date

A $620,000 Portfolio That Pays More Than the Average Social Worker’s Salary

Prediction: Pfizer Stock Will Double on This Date

SMH ETF Investors: Watch Hyperscaler Capex Guidance at July Earnings Calls

Featured Reads

A $620,000 Portfolio That Pays More Than the Average Social Worker's Salary

The Average American Has Worked for 6 Employers and 23% Still Have Multiple Old Retirement Accounts, Fidelity's 2026 Study Finds